Synthesized in the USA
Lab & COAs
Every batch is third-party tested before release. Find the batch number on your label. Every batch is tested for identity and purity by an independent third-party laboratory before release. Find the batch number on your label and download its certificate.
- 01Synthesized in San Diego, CA
- 02Tested by an independent lab
- 03COA published per batch
- Retatrutide · 20 mg RET20VAS0626 · 99.0% PDF RET20VAS0626
- Retatrutide · 40 mg RET40VAS0526 · >99.5% PDF RET40VAS0526
- Retatrutide · 10 mg RET10VAS0526 · >99.3% PDF RET10VAS0526
- Retatrutide · 20 mg RET20N0426 · >99.3% PDF RET20N0426
- Retatrutide/Semaglutide · 25 mg / 40 mg RS4025N1125 · >99.0% PDF RS4025N1125
- Retatrutide · 40 mg RET40N1125 · >99.0% PDF RET40N1125
- Retatrutide · 20 mg RET20N1125 · >99.0% PDF RET20N1125
| Product | Form | Strength | Batch | Tested | Purity | COA |
|---|---|---|---|---|---|---|
| Retatrutide | Vial | 20 mg | RET20VAS0626 | 08 Jun 2026 | 99.0% | PDF ↓ RET20VAS0626 |
| Retatrutide | Vial | 40 mg | RET40VAS0526 | 08 May 2026 | >99.5% | PDF ↓ RET40VAS0526 |
| Retatrutide | Vial | 10 mg | RET10VAS0526 | 08 May 2026 | >99.3% | PDF ↓ RET10VAS0526 |
| Retatrutide | Nasal | 20 mg | RET20N0426 | 08 May 2026 | >99.3% | PDF ↓ RET20N0426 |
| Retatrutide/Semaglutide | Nasal | 25 mg / 40 mg | RS4025N1125 | 24 Nov 2025 | >99.0% | PDF ↓ RS4025N1125 |
| Retatrutide | Nasal | 40 mg | RET40N1125 | 13 Nov 2025 | >99.0% | PDF ↓ RET40N1125 |
| Retatrutide | Nasal | 20 mg | RET20N1125 | 13 Oct 2025 | >99.0% | PDF ↓ RET20N1125 |
Showing 7 of 7 certificates
Testing lab: AxisPharm, LLC